United States Pharmacogenomics Market to Reach $8.87B by 2033 - Key Trends & Insights | Top Companies are Abbott Laboratories, Agilent Technologies Inc, Becton.

The global pharmacogenomics market was valued at US$ 3.59 Billion in 2023. The market size reached US$ 3.92 Billion in 2024 and is expected to reach US$ 8.87 Billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.

The Pharmacogenomics market focuses on the study of how genes affect individual responses to drugs. Applications include personalized medicine, adverse drug reaction prediction, and optimized therapy selection. Growing demand for precision healthcare and targeted treatments drives market growth. Advancements in genomic sequencing, bioinformatics, and clinical applications enhance adoption. Rising healthcare investments and increasing awareness of personalized therapies further support expansion.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Pharmacogenomics Market Landscape:- https://datamintelligence.com/download-sample/pharmacogenomics-market?rk

☛ Pharmacogenomics Market Recent Developments 2025:

United States: Recent Pharmacogenomics Developments
✅ In September 2025, Quest Diagnostics launched an advanced pharmacogenomics (PGx) test in collaboration with Coriell Life Sciences. This service empowers clinicians with personalized genetic insights to optimize prescribing across specialties.

✅ In August 2025, the FDA approved a once-weekly subcutaneous injection of Leqembi (lecanemab-irmb) for maintenance dosing in early Alzheimer's disease. This personalized therapy considers genetic factors, specifically ApoE e4 carriers.

✅ In July 2025, the U.S. Department of Veterans Affairs expanded its pharmacogenomics program by increasing the number of genes tested from 16 to 22. This expansion aims to prevent life-threatening anesthesia complications and antibiotic-related hearing loss.

Japan: Recent Pharmacogenomics Developments
✅ In August 2025, Japan's pharmacogenomics market was valued at USD 378.4 million in 2024, with projections to reach USD 671.1 million by 2033, reflecting a CAGR of 6.08% from 2025 to 2033.

✅ In December 2023, Japan's Ministry of Health, Labour and Welfare released new guidelines stating that, in principle, an additional Japanese Phase 1 study prior to multi-regional clinical trials (MRCTs) is not needed unless deemed necessary after assessing safety and tolerability in Japanese participants.

✅ In October 2024, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) introduced a guideline for orphan drugs, allowing possible new drug applications without Japanese clinical trial data. This aims to expedite drug development and reduce "drug loss" in Japan.

☛ Pharmacogenomics Market Trends:

Rising demand for personalized medicine, driven by growing awareness of genetic influences on drug efficacy and safety, which enhances treatment outcomes and minimizes adverse drug reactions.

Increasing prevalence of chronic and genetic diseases like cancer, cardiovascular diseases, diabetes, and neurological disorders, creating a need for more effective, tailored therapies.

Advancements in genomic technologies such as next-generation sequencing, microarray analysis, and bioinformatics tools, which improve the accuracy and efficiency of pharmacogenomic testing.

Increasing investments in R&D by pharmaceutical companies and government initiatives promoting precision medicine and genomic research.

Integration of pharmacogenomic data into electronic health records (EHRs) and adoption of AI-driven decision support tools that facilitate the clinical application of pharmacogenomics.

Expansion of companion diagnostics and regulatory approvals for personalized therapies, particularly in oncology.

☛ Pharmacogenomics Market Competitve Landscape:

Abbott Laboratories, Agilent Technologies Inc, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc, Illumine, Eurofins Scientific, Pacific Biosciences of California Inc, Qiagen and Thermo Fisher Scientific Inc.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/pharmacogenomics-market

☛ Segment Covered in the Pharmacogenomics Market:

By Type: Genotyping Kits, Sequencing Instruments, PCR Reagents and Consumables, Sample Preparation Kits, Others, ServicesGenetic Testing Services, Pharmacogenomic Consulting, Others, SoftwareBioinformatics Software, Clinical Decision Support System, Laboratory Information Management System, EHR Integration Software, Others

By Technology: DNA Sequencing , Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Other Technologies

By Application: Drug Discovery, Neurology, Oncology, Pain Management, Other Applications

By End User: Hospital , Specialty Clinics, Academic and Research Institutes, Pharmaceuticals

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Pharmacogenomics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=pharmacogenomics-market

☛ Regional Analysis for Pharmacogenomics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Pharmacogenomics Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Pharmacogenomics Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Pharmacogenomics Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.